Search results
10 sty 2024 · Clinicians should recommend treatment according to menopausal status, pathological and biomarker features when quality results are available. In first-line, for hormone receptor (HR)–positive MBC, when a non-steroidal aromatase inhibitor and CDK 4/6 inhibitor combination is unavailable, use hormonal therapy alone.
28 cze 2001 · The majority of women with breast cancer treated with adjuvant chemotherapy have mild or moderate nausea and vomiting, but these symptoms are severe in less than 5 percent of women .
1 gru 2023 · To reduce the side effects or toxicities brought on by chemotherapy, a variety of medications and nutritional supplements are used. Also numerous physical side effects of breast cancer treatment may be prevented and managed with the help of rehabilitation and exercise, according to evidence.
6 sie 2019 · Endocrine therapy is indicated in all patients with hormone receptor-positive breast cancer as well as those with low-positive cancer (≥1–9%; LoE 1/GR A/AGO++). In case of ER negativity/progesterone receptor (PR) positivity (≥10%), immunohistochemical reevaluation should be performed.
Learn about the possible side effects of chemotherapy for breast cancer - which are usually temporary - and how they can be managed or controlled.
For breast cancers that are considered HER2-low and have spread to distant sites, the antibody-drug conjugate fam-trastuzumab deruxtecan (Enhertu) might be an option. HER2-negative cancers in women with a BRCA gene mutation.
18 sty 2022 · Adjuvant bisphosphonate therapy should be discussed with all postmenopausal patients (natural or therapy-induced) with primary breast cancer, irrespective of hormone receptor status and human epidermal growth factor receptor 2 status, who are candidates to receive adjuvant systemic therapy.
